Erin Bastick, PharmD, RPh
Insurer diabetes program engages consumers, lowers costs
Insurer diabetes program engages consumers, lowers costs
Anthem Blue Cross recently launched a year-long diabetes prevention program to educate, treat and support its qualified California members who are at risk of developing type 2 diabetes.
Drug pipeline developments: Alopecia areata and atopic dermatitis
Promising treatments are coming for alopecia areata and atopic dermatitis, but they will come at a high cost.
Know these barriers to reduce type 2 diabetes costs
IMS Health study: Up to 15% of healthcare system costs avoidable and effective patient activation by multiple stakeholders is key to driving improvement.
Aggressive blood sugar control slows diabetic eye disease progression
NIH-funded study shows less diabetic retinopathy progression among those who underwent intensive glycemic control.
Patient navigators can benefit diabetes outcomes
Study seeks to determine whether significant improvement in glycemic control can be achieved when regular coaching is part of the process.

Poll

View Results